Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.
Open | $49.04 |
Close | $49.79 |
Volume / Avg. | 1.25M / 562.85K |
Day Range | $48.05 - $50.25 |
52 Wk Range | 9.60 - 50.69 |
Market Cap | $3.22B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 16.17% |
Days to Cover | 19.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.
Other companies in Kymera Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
Kymera Therapeutics has a consensus price target of $46.47.
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $49.79 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Kymera Therapeutics.
Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Kymera Therapeutics.
Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.